ER, PgR, Ki67, p27(Kip1), and histological grade as predictors of pathological complete response in patients with HER2-positive breast cancer receiving neoadjuvant chemotherapy using taxanes followed by fluorouracil, epirubicin, and cyclophosphamide concomitant with trastuzumab

BACKGROUND: Neoadjuvant chemotherapy (NAC) with taxanes followed by fluorouracil, epirubicin, and cyclophosphamide (FEC), and concurrent trastuzumab is a potent regimen for HER2 over-expressing breast cancer. A high pathological complete response (pCR) rate has been achieved using this regimen; howe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurozumi, Sasagu, Inoue, Kenichi, Takei, Hiroyuki, Matsumoto, Hiroshi, Kurosumi, Masafumi, Horiguchi, Jun, Takeyoshi, Izumi, Oyama, Tetsunari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562359/
https://www.ncbi.nlm.nih.gov/pubmed/26345461
http://dx.doi.org/10.1186/s12885-015-1641-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562359/
https://www.ncbi.nlm.nih.gov/pubmed/26345461
http://dx.doi.org/10.1186/s12885-015-1641-y

Ejemplares similares